This 10 minute presentation will provide you with an exploration of how illicit compounding intersects with
patent protections, market exclusivity, and the proposed EU pharma package revisions shaping the future of
pharmaceutical innovation.
Speaker(s):
Raquel Frisardi
Senior Corporate Counsel
Novo Nordisk
Time:
13:00pm-13:10pm
Agenda Track No.:
Track 1
Session Type:
General Session (Presentation)
Force Inline Description:
0